THE DETECTION AND QUANTIFICATION OF ETHYL GLUCURONIDE IN PLACENTAL TISSUE AND PLACENTAL PERFUSATE BY HEADSPACE SOLID-PHASE MICROEXTRACTION COUPLED WITH GAS CHROMATOGRAPHY-MASS SPECTROMETRY

Main Article Content

Jeremy N Matlow
Katarina Aleksa
Angelika Lubetsky
Gideon Koren

Keywords

Ethyl glucuronide, gas chromatography, headspace solid-phase microextraction, biomarker, placenta, ex vivo placental perfusion model

Abstract

Background


Ethyl glucuronide (EtG) is arising as a promising biomarker of heavy prenatal alcohol exposure, however its transfer across the human placenta is still unclear and is currently being investigated using the ex vivo placental perfusion model. This model allows for sampling from placental tissue and placental perfusate, which is a surrogate to plasma.


 


Objective


To develop a method for detecting and quantifying EtG in placental perfusate and tissue using headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography-mass spectrometry (GC-MS).


 


Methods


A method was optimized by manipulation of the following components to attain the highest peak counts for the quantifying ions of EtG and its deuterated internal standard on the mass spectrum: cartridges used for solid phase extraction, injection method, derivatizing agent, pre-injection parameters, SPME fiber, GC ramp speed, and GC column flow.


 


Results


The final method utilized involved solid phase extraction of standards via UCT CleanScreen Cartridges, derivatization with heptafluorobutyric acid, and introduction into the GC via HS-SPME with adsorption to a polydimethylsiloxane fiber. The method has improved sensitivity over other methods that quantify EtG in blood using GC-MS, with detection limits of 1.6 ng/mL and 13.7 ng/g for placental perfusate and tissue, respectively. The method was applied to samples collected from the fetal reservoir during the ex vivo placental perfusion model and EtG was detected in the fetal circulation after 20 minutes of perfusion, indicating transfer of EtG.


 


Conclusions


The present method is sensitive and can be used to quantify EtG transfer during ex vivo placental perfusion experiments.

Abstract 14 | PDF Downloads 8

References

1. Foti RS, Fischer MB. Assessment of UDPglucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int 2005;153:109-116.
2. Halter CC, Dresen S, Auwaerter V, Wurst FM, Weinmann W. Kinetics in serum and urine excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake. Int J Legal Med 2008;122: 123-128.
3. Hoiseth G, Bernard JP, Karinen R, et al. A pharmacokinetic study of ethyl glucuronide in blood and urine: applications to forensic toxicology. Forensic Sci Int 2007;172:119- 124.
4. Hoiseth G, Morini L, Polettini A, Christophersen A, Morland J. Blood kinetics of ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Forensic Sci Int 2009;188:52-26.
5. Borucki K, Schreiner R, Dierkes J, et al. Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5- hydroxyindole acetic acid in urine. Alcohol Clin Exp Res 2005;29:781-787.
6. Gareri J, Lynn H, Handley M, Rao C, Koren G. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther Drug Monit 2008;30: 239-245.
7. Backdash A, Burger P, Goecke TW, et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal Bioanal Chem 2010;396:2469- 2477.
8. Morini L, Groppi A, Marchei E, et al. Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 Mediterranean cohorts. Ther Drug Monit 2010;32:359-363.
9. Pichini S, Marchei E, Magnarelli F, et al. Assessment of prenatal exposure to ethanol by meconium analysis: results of an Italian multicenter study. Alcohol Clin Exp Res 2012;36:417-424.
10. Tarcomnicu I, van Nuijs AL, Aerts K, et al. Ethyl glucuronide determination in meconium and hair by hydrophilic interaction liquid chromatography-tandem mass spectrometry. Forensic Sci Int 2010; 196:121-127.
11. Morini L, Falcon M, Pichini S, et al. Ethylglucuronide and ethyl-sulfate in placental and fetal tissues by liquid chromatography coupled with tandem mass spectrometry. Anal Biochem 2011;418: 30-36.
12. Hutson JR, Garcia-Bournissen F, Davis A, Koren G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther 2011;90:67-76.
13. Janda I, Alt A. Improvement of ethyl glucuronide determination in human urine and serum samples by solid-phase extraction. J Chromatogr B Biomed Sci Appl 2001;758:229-234.
14. Schmitt G, Aderjan R, Keller T, Wu M. Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol 1995;19:91-94.
15. Shen BH, Yan H, Zhao H, Zhuo XY. [Determination of ethyl glucuronide in blood by GC-MS/MS]. Fa Yi Xue Za Zhi 2009;25:431-433.
16. Pragst F. Application of solid-phase microextraction in analytical toxicology. Anal Bioanal Chem 2007;388:1393-1414.
17. Miller RK, Wier PJ, Maulik D, di Sant'Agnese PA. Human placenta in vitro: characterization during 12 h of dual perfusion. Contrib Gynecol Obstet 1985;13:77-84.
18. Derewlany LO, Leeder JS, Kumar R, et al. The transport of digoxin across the perfused human placental lobule. J Pharmacol Exp Ther 1991;256:1107-1011.
19. Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP-singlenucleotide polymorphism. Drug Metab Dispos 2010;38:740-744.
20. Kerekes I, Yegles M, Grimm U, Wennig R. Ethyl glucuronide determination: head hair versus non-head hair. Alcohol Alcohol 2009;44:62-66.
21. Yegles M, Labarthe A, Auwarter V, et al. Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic Sci Int 2004;145: 167-173.
22. Agius R, Nadulski T, Kahl HG, et al. Validation of a headspace solid-phase microextraction-GC-MS/MS for the determination of ethyl glucuronide in hair according to forensic guidelines. Forensic Sci Int 2010;196:3-9.
23. Hoiseth G, Yttredal B, Karinen R, et al. Ethyl glucuronide concentrations in oral fluid, blood, and urine after volunteers drank 0.5 and 1.0 g/kg doses of ethanol. J Anal Toxicol 2010;34:319-324.
24. Hoiseth G, Morini L, Polettini A, et al. Serum/whole blood concentration ratio for ethylglucuronide and ethyl sulfate. J Anal Toxicol 2009;33:208-211.
25. Aleksa K, Walasek P, Fulga N, et al. Simultaneous detection of seventeen drugs of abuse and metabolite in hair using solid phase micro extraction (SPME) with GC/MS. Forensic Sci Int 2012;218: 31-36.
26. Pawliszyn J, Pawliszyn B, Pawliszyn M. Solid phase microextraction (SPME). Chem Educator 1997;2:1-7.
27. Jurado C, Soriano T, Gimenez MP, Menendez M. Diagnosis of chronic alcohol consumption. Hair analysis for ethyl-glucuronide. Forensic Sci Int 2004;145:161-166.